Jean-Philippe Collet

Showing 1-8 of 8 articles

Coronary interventions

Impact of age on the effect of pre-hospital P2Y12 receptor inhibition in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: the ATLANTIC-Elderly analysis

Collet J-P, Kerneis M, Lattuca B, Yan Y, Cayla G, Silvain J, Lapostolle F, Ecollan P, Diallo A, Vicaut E, Hamm C, van’t Hof A, Montalescot G

September 20, 2018 | 10.4244/EIJ-D-18-00182

STEMI

The efficacy of early versus delayed P2Y12 inhibition in percutaneous coronary intervention for ST-elevation myocardial infarction: a systematic review and meta-analysis

Bellemain-Appaix A, Begue C, Bhatt D, Ducci K, Harrington R, Roe M, Wiviott SD, Cucherat M, Silvain J, Collet J-P, Bernasconi F, Montalescot G

May 20, 2018 | 10.4244/EIJ-D-17-00852

Interventions for heart failure

Outcome after revascularisation of acute myocardial infarction with cardiogenic shock on extracorporeal life support

Overtchouk P, Pascal J, Lebreton G, Hulot J-S, Luyt C-E, Combes A, Kerneis M, Silvain J, Barthelemy O, Leprince P, Brechot N, Montalescot G, Collet J-P

April 6, 2018 | 10.4244/EIJ-D-17-01014

Intravenous enoxaparin anticoagulation in percutaneous left atrial cardiac procedures

Guedeney P, Hammoudi N, Duthoit G, Yan Y, Silvain J, Pousset F, Isnard R, Redheuil A, Kerneis M, Collet J-P, Montalescot G

November 20, 2017 | 10.4244/EIJ-D-17-00518

Interventions for valvular disease

Antithrombotic therapy in TAVI patients: changing concepts

Gargiulo G, Collet J-P, Valgimigli M

September 17, 2015 | 10.4244/EIJV11SWA28

Triple antithrombotic therapy in atrial fibrillation patients with acute coronary syndromes or undergoing percutaneous coronary intervention or transcatheter aortic valve replacement

Capodanno D, Lip G, Windecker S, Huber K, Kirchhof P, Boriani G, Lane D, Gilard M, Collet J-P, Valgimigli M, Byrne R

January 22, 2015 | 10.4244/EIJV10I9A174

2014 ESC/EACTS Guidelines on myocardial revascularization

Windecker S, Kolh P, Alfonso F, Collet J-P, Cremer J, Falk V, Filippatos G, Hamm C, Head S, Jüni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann F, Richter D, Schauerte P, Uva M, Stefanini G, Taggart D, Torracca L, Valgimigli M, Wijns W, Witkowski A

January 22, 2015 | 10.4244/EIJY14M09_01

Antithrombotic and antiplatelet therapy in TAVI patients: a fallow field?

Collet J-P, Montalescot G

September 15, 2013 | 10.4244/EIJV9SSA9

1

Latest news

LM revascularisation, annulus rupture, risk stratification, renal denervation

EAPCI survey results: The impact of COVID-19

Marco Roffi, Dariusz Dudek, et al.

A perspective from EAPCI Women and Women as One

Gill Louise Buchanan

Last Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI

(supported by Biotronik)

Guidance Papers

Guidelines, consensus & position papers

EuroIntervention new Editorial Board

This week’s JAA’s: Paradigm Study: 12months outcome, GLASSY ACS vs SIHD...

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke